Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M KELLY

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Glia|September 15, 2005
Calcium-activated chloride channels in müller cells acutely isolated from tiger salamander retinaNicole C Welch, Melanie R Lalonde, Steven Barnes, et al.
Journal of Basic and Clinical Physiology and Pharmacology|February 6, 2013
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gutMandana Kianian, Nadia A Al-Banna, Melanie E M Kelly, et al.
Neurourology and Urodynamics|August 5, 2021
Rodent models of ketamine-induced cystitisSaki Sultana, Geraint Berger, Ashley Cox, et al.
Clinical Hemorheology and Microcirculation|October 12, 2013
Leukocyte-endothelial interactions within the ocular microcirculation in inflammation and infectionN A Al-Banna, J T Toguri, M E M Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2011
Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressureAnna-Maria Szczesniak, Yehoshua Maor, Harold Robertson, et al.
Molecular Pharmacology|December 25, 2015
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington DiseaseRobert B Laprairie, Amina M Bagher, Melanie E M Kelly, et al.
Molecular Pharmacology|April 8, 2016
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection NeuronsAmina M Bagher, Robert B Laprairie, Melanie E M Kelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2011
Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonistsBrian D Hudson, Meggie Beazley, Anna-Maria Szczesniak, et al.
British Journal of Pharmacology|July 29, 2015
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptorR B Laprairie, A M Bagher, M E M Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Ocular hypotensive effects of an intratracheally delivered liposomal delta9-tetrahydrocannabinol preparation in ratsAnna-Maria Szczesniak, Melanie E M Kelly, Sara Whynot, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Glia|September 15, 2005
Calcium-activated chloride channels in müller cells acutely isolated from tiger salamander retinaNicole C Welch, Melanie R Lalonde, Steven Barnes, et al.
Journal of Basic and Clinical Physiology and Pharmacology|February 6, 2013
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gutMandana Kianian, Nadia A Al-Banna, Melanie E M Kelly, et al.
Neurourology and Urodynamics|August 5, 2021
Rodent models of ketamine-induced cystitisSaki Sultana, Geraint Berger, Ashley Cox, et al.
Clinical Hemorheology and Microcirculation|October 12, 2013
Leukocyte-endothelial interactions within the ocular microcirculation in inflammation and infectionN A Al-Banna, J T Toguri, M E M Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2011
Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressureAnna-Maria Szczesniak, Yehoshua Maor, Harold Robertson, et al.
Molecular Pharmacology|December 25, 2015
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington DiseaseRobert B Laprairie, Amina M Bagher, Melanie E M Kelly, et al.
Molecular Pharmacology|April 8, 2016
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection NeuronsAmina M Bagher, Robert B Laprairie, Melanie E M Kelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2011
Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonistsBrian D Hudson, Meggie Beazley, Anna-Maria Szczesniak, et al.
British Journal of Pharmacology|July 29, 2015
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptorR B Laprairie, A M Bagher, M E M Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Ocular hypotensive effects of an intratracheally delivered liposomal delta9-tetrahydrocannabinol preparation in ratsAnna-Maria Szczesniak, Melanie E M Kelly, Sara Whynot, et al.
Pageof 11